Funded Tech Companies

Crossbow Therapeutics

Crossbow Therapeutics is a biopharmaceutical tech company, located in Cambridge. Venture investment and financing was provided by Eli Lilly and Company, Pfizer Venture Investments and Taiho Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company's T-Bolt� therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow's efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/19/2026

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Briggs Morrison

        

Chief Scientific Officer

Dmitri Wiederschain

        

Co-Founder

Geraldine Paulus

        

Company Investors

• Eli Lilly and Company
• Pfizer Venture Investments
• Taiho Ventures
• Mirae Asset Venture Investment
• BVF Partners
• Polaris Partners
• Arkin Bio-Ventures
• LifeLink Ventures
• Sixty Degree Capital
• MPM Capital
• The Leukemia & Lymphoma Society
• Mirae Asset Capital

Browse more funded tech companies:

Crossbow Technology | CrossBridge Bio

Share this article

About Our VC Deals Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary